...
首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection.
【24h】

Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection.

机译:鳞状细胞癌从不明的头颈部粘膜部位转移到颈部淋巴结,单独接受放射治疗或联合颈淋巴结清扫术。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: The present study presents the experience at the University of Florida with treatment of patients with squamous cell carcinomas (SCC) metastatic to cervical lymph nodes from an unknown head-and-neck mucosal (H&NM) site with radiotherapy (RT) alone or in combination with neck dissection (ND). METHODS AND MATERIALS: The study included 126 patients treated with curative intent from 1964 to 1997. All patients had follow-up for at least 2 years. No patients were lost to follow-up. RESULTS: Twelve patients (10%) developed SCC in H&NM sites at 0.5 to 10.9 years (median, 1.8 years). The rate of developing carcinomas in H&NM sites at 5 years was 13%. Histologic differentiation significantly affected the rate of developing carcinomas in H&NM sites in multivariate analysis. Sixteen patients (13%) had persistent nodal disease and 12 patients (10%) developed recurrent nodal disease at 0.5 to 10.9 years (median, 1.1 years). The nodal control rate at 5 years was 78%. Nodal size, N stage, and planned ND significantly affected the rate of nodal control in multivariate analysis. Nineteen patients (15%) developed distant metastasis at 0.2-5.1 years (median, 0.9 years). The distant metastases rate at 5 years was 14%. Extracapsular extension and RT dose significantly affected the risk of distant metastases in multivariate analysis. The overall absolute survival rate at 5 years was 47%. Extracapsular extension, N stage, RT dose for H&NM sites, and planned ND significantly affected absolute survival in multivariate analysis. The rate of cause-specific survival at 5 years was 67%. Extracapsular extension, nodal size, N stage, overall treatment time, and planned ND significantly affected cause-specific survival in multivariate analysis. Eight patients (6%) had severe postoperative complications and 6 patients (5%) had severe late complications. CONCLUSION: The present study supports the effectiveness of RT in lowering the rate of developing carcinomas in the H&NM sites.
机译:目的:本研究介绍了佛罗里达大学在单独或在放疗(RT)中治疗从未知头颈粘膜(H&NM)部位转移至宫颈淋巴结的鳞状细胞癌(SCC)患者的经验。结合颈清扫术(ND)。方法和材料:该研究纳入了1964年至1997年接受治疗的126例患者。所有患者均接受了至少2年的随访。没有患者失去随访。结果:12名患者(10%)在H&NM部位发展为SCC,时间为0.5至10.9岁(中位数为1.8岁)。 5年内H&NM部位发生癌的比例为13%。在多变量分析中,组织学分化显着影响了H&NM位点中发生癌的比率。 16例(13%)患有持续性淋巴结病,12例(10%)在0.5至10.9年(中位数为1.1年)发展为复发性淋巴结病。 5年时的结节控制率为78%。在多变量分析中,淋巴结大小,N分期和计划的ND显着影响淋巴结控制率。 19例患者(15%)在0.2-5.1年(中位0.9年)发生远处转移。 5年时远处转移率为14%。在多变量分析中,囊外延伸和RT剂量显着影响远处转移的风险。 5年总的绝对生存率为47%。在多变量分析中,囊外延伸,N期,H&NM部位的RT剂量和计划的ND显着影响绝对生存率。 5年时特定原因的存活率为67%。在多变量分析中,囊外扩展,淋巴结大小,N期,总体治疗时间和计划的ND显着影响了特定原因的生存。 8例(6%)术后严重并发症,6例(5%)晚期严重并发症。结论:本研究支持RT在降低H&NM位点发展中癌症的发生率方面的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号